Drug-eluting stenting for femoropopliteal lesions, followed by cilostazol treatment, reduces stent restenosis in patients with symptomatic peripheral artery disease. [electronic resource]
Producer: 20170517Description: 720-725 p. digitalISSN:- 1097-6809
- Aged
- Aged, 80 and over
- Cardiovascular Agents -- administration & dosage
- Cilostazol
- Constriction, Pathologic
- Drug-Eluting Stents
- Endovascular Procedures -- adverse effects
- Female
- Femoral Artery -- diagnostic imaging
- Humans
- Japan
- Logistic Models
- Male
- Middle Aged
- Odds Ratio
- Paclitaxel -- administration & dosage
- Peripheral Arterial Disease -- complications
- Platelet Aggregation Inhibitors -- administration & dosage
- Popliteal Artery -- diagnostic imaging
- Propensity Score
- Prospective Studies
- Prosthesis Design
- Recurrence
- Registries
- Risk Factors
- Tetrazoles -- administration & dosage
- Time Factors
- Treatment Outcome
- Ultrasonography, Doppler, Duplex
- Vascular Patency -- drug effects
No physical items for this record
Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.